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Aluminium (Al) exposuremay affect the liver of experimental animals. This investigation  aimed at evaluating 
morphological changes in rat liver after a single high dose of Al (as metallic powder suspension). A 
total of forty female Wistar rats were divided in one exposed and one control group, 20 rats each. The 
exposed rats received 0.5 mL of sterile physiological suspension of fine Al powder in the concentration of 
100 mg mL-1 intraperitoneally (50 mg Al per rat). After 7 weeks all animals were killed (by exsanguination 
from the abdominal aorta in ether anaesthesia). Liver aluminium was analysed using electrothermal atomic 
absorption spectrometry. For light microscopy the liver tissue was stained with hematoxylin and eosin, and 
for histochemical analysis with aurin threecarbocsillic acid (aluminon).
Liver Al level was markedly higher in the exposed (37.1 µg g-1) than in control rats (0.71 µg g-1). The 
exposed rats showed crystalloid Al inclusions in the capsular, subcapsular, and portal liver tissue. The basic 
liver structure remained intact. Slightly multiplied bile ductuli were found in 16 of 20 exposed and in 8 of 
20 control rats. Three exposed rats had mycrovesicular steatosis. The peritoneum and Glisson’s capsule 
showed strong macrophage infiltration and a foreign-body-like reaction with multiple giant macrophages 
containing Al crystalloid inclusions. Although this reaction was a defense against the metal, some Al passed 
this barrier and entered the liver tissue, exerting toxic effects in bile ductuli and hepatocytes.
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Aluminium (Al) is a silvery white, shiny, extremely 
reactive metal available everywhere in the environment, 
in the soil, water and air. It was discovered in 1827, 
and its production started twenty years later. Today 
aluminium is used in almost all industrial fields, 
agriculture, and traffic. Exposure to Al is almost 
inevitable, since it is present in water, air, and food, as 
well as in drugs, as an active substance or an additive. It 
was not until 1975 that Al attracted attention, when the 
first case of encephalopathy was associated with high 
quantities of Al in brain cells (1). This encephalopathy 
was found in patients on chronic dialysis or in heavily 
exposed workers (e. g. welders). This encouraged a 
more intense research of Al toxic effects. Beside the 
brain, Al in high doses was also shown to damage the 
kidneys, bones, heart, and lungs (2-5).
Hepatotoxic effects of Al were considered less 
important, despite the fact that Al accumulates in 
macrophages and in hepatocyte organelles such as 
lysosomes (3, 6).
The aim of this study was to assess morphological 
changes in the liver tissue after parenteral exposure to 
Al (water suspension of pure Al powder). This research 
provided additional evidence to our clinical findings 
in workers occupationally exposed to Al.
* This paper has partly been presented at the International Symposium 
Safety and Health at Work in Metal Industry: 2007 - Focus on Aluminium 
Industry” held in Šibenik, Croatia on 24-26 May 2007.
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MATERIALS AND METHODS
Experimental research was conducted on 40 
female two-month-old Wistar rats of similar body 
weight between 280 g and 320 g. The rats were 
divided in two groups, 20 in the exposed and 20 in 
the control group.
The experimental protocol observed the Guide 
for the Care and Use of Laboratory Animals (7). Rats 
were kept in cages with a 12-hour light/dark cycle 
at controlled temperature (21 °C to 25 °C), fed with 
standard rodent feed, and given tap water ad libitum.
During a three-week quarantine no clinical changes 
in the appearance and/or behaviour were observed. 
Before the start of the experiment, one animal was 
killed from each cage, and post mortem findings 
confirmed that the animals were healthy.
Fine Al powder (aluminium metallic pulvis 
subtilis by Kemika Zagreb, Croatia) was suspended
(100 mg mL-1) in a sterile physiological solution, and 
0.5 mL of suspension containing 50 mg Al was injected 
intraperitoneally to each rat in the exposed group. This 
dose was based on earlier investigations (8, 9).
Control rats did not receive anything at all. All 
animals were killed by exsanguination from the 
abdominal aorta in ether anaesthesia seven weeks 
after Al administration.
Liver was dissected from each animal and 
one part used to determine Al mass fraction per 
gram of wet liver tissue , while the other part was 
used for histological analysis. Liver tissue Al  was 
determined using a electrothermal atomic absorption 
spectrophotomer (ET AAS) “Unicam” SP 90 A (10). 
Statistical differences between the exposed and 
control groups were analysed using Student’s t-test.
For morphological observation by light microscopy 
liver tissues were fixed in 10 % neutral formaldehyde 
solution, dehydrated in ascending ethanol series, and 
embedded in paraffin. Sections were stained with 
hematoxylin and eosin (H&E), and for histochemical 
analysis with aurin threecarbocsillic acid (aluminon) 
using Irwin’s method (10, 11).
The analysis included basic liver structure, portal 
tracts, acini in sinusoidal and perisinusoidal spaces, 
and Glisson’s capsule.
RESULTS
Average liver Al in the exposed rats was 
(37.1±14.72) µg g-1 wet weight (N=11) and in 
controls (0.71± 0.22) µg g-1 wet weight (N=16).
Light microscopy showed that the basic liver 
structure remained intact. In the exposed rats, portal 
areas, which were of standard dimensions, had several 
gently pigmented, Al-positive macrophages (found 
in 18 of 20 samples). No macrophage was found 
in control liver samples. In 16 of 20 samples of the 
exposed and in eight of 20 samples of control rats, 
bile ductuli were slightly multiplied.
No specific changes were detected in the liver 
parenchyma in the exposed rats, but micro-vascular 
fatty changes were found in the hepatocytes of three 
(of 20) liver samples. No such changes were observed 
in control rat samples. Sinusoidal and perisinusoidal 
cells did not show any specific changes.
Glisson’s capsule of the exposed rats showed a very 
strong macrophage reaction that looked like a reaction 
to a foreign body. It was evidenced by granulomatous 
changes, in which cells, often gigantic, were infiltrated 
by black rough Al particles of crystalloid structure. 
Granulomatous reaction with pigmentation, in fact 
crystalloid inclusions, was found in the subcapsular liver 
tissue, including the portal area (Figures 1, 2, and 3).
DISCUSSION
In experimental research, Al was administered 
orally, parenterally and intracranially to laboratory 
animals, but mainly in the form of Al compounds 
(12). In 1979, Ellis et al. (13) injected aluminium 
chloride intraperitoneally to laboratory rats, and 
noticed changes in the bones. These results were later 
confirmed by Goodman et al. (14) in 1984. Tetsuji and 
Kiyokazu (6) found that after oral administration of 
aluminium in water solution, Al accumulated in the 
liver, kidneys, and intestines, but not in the brain, and 
using an electronic microscope (EDX) they detected 
an accumulation of Al in lysosomes and vesicles of 
hepatocytes.
Until now most attention has been paid to 
experimental research of Al neurotoxic effects. There 
are a relatively small number of data related to Al 
toxic effects on the liver functionality and morphology. 
According to Galle et al. (15), Al does not produce 
toxic effects in the liver because it is eliminated from 
hepatocytes into the bile together with lysosomes.
On the other hand, Abubakar et al. (16) ascertained 
that Al in hepatocytes, even in small quantities, is 
associated with an increase in reactive oxygen species 
and lipid peroxidation. Gonzales et al. (5) pointed 
out a hepatocyte dysfunctionin terms of reduced 
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in the liver. It penetrated the liver through Glisson’s 
capsule, and  lymph.
Furthermore, histochemical staining showed 
that Al accumulated in phagocytes of the portal 
area (macrophagocytes and Kupffer cells) as well 
as in macrophagocytes of the subcapsular area. 
It was not observed in either the cytoplasm or the 
organelles of hepatocytes. Even if Al did accumulate 
in the organelles, and especially in lysosomes, its 
quantities were too small to be stained by aluminon. 
Larger particles behaved as a strange body and were 
immediately overtaken by macrophagocytes. In the 
capsular and subcapsular area, where Al was detected, 
the granulomatous reaction was significant.
In addition to changes in Glisson’s capsule 
and in the subcapsular area in the exposed rats, 
specific changes were also observed in the portal 
area and acini, which were not seen in the liver of 
the control animals. These changes included slight 
microvascular fatty changes, Kupffer cell hyperplasia, 
and multiplication of bile canalicules, showing that Al 
reached all liver structures. This suggest that some 
metal particles passed the macrophagocyte barrier.
CONCLUSION
Our results have demonstrated that Al injected 
intraperitoneally accumulates in the liver of 
experimental rats. Only in these rats did we detect 
morphological changes in the liver tissue such as 
slight proliferation of bile ductuli and microvesicular 
steatosis.
Even though abnormal experimental Al exposure 
such as ours usually does not occur in human beings, 
our finding may help in further investigations of Al 
hepatotoxic effects.
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Figure 1 Stained subcapsular liver granulomatous reaction in rats 
administered a single peritoneal injection of suspended 
aluminium (staining by aluminon; magnified 63x)
Figure 2 Slightly multiplied bile ductuli in in rats administered a single 
peritoneal injection of suspended aluminium (staining by H&E 
eosin; magnified 320x)
Figure 3 Liver portal area with stained phagocytes in rats administered 
a single peritoneal injection of suspended aluminium (staining 
by H&E and aluminon; magnified 320x)
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Sa`etak
PATOHISTOLO[KE PROMJENE U JETRI [TAKORA NAKON JEDNOKRATNOG IZLAGANJA VISOKOJ 
DOZI ALUMINIJA
Izlo`enost aluminiju (Al) mo`e izazvati o{te}enje jetre u eksperimentalnih `ivotinja. Cilj istra`ivanja bio je 
procijeniti morfolo{ke promjene u jetri {takora nakon jednokratnog davanja visoke doze aluminija (suspenzije 
metalnog praha). ^etrdeset albino Wistar {takorica bilo je podijeljeno u izlo`enu i kontrolnu skupinu. 
Izlo`enoj skupini ubrizgano je intraperitonealno 0,5 mL sterilne suspenzije praha aluminija u fiziolo{koj 
otopini (100 mg mL-1), odnosno 50 mg Al po {takorici. Nakon sedam tjedana {takorice su usmr}ene 
(iskrvarenjem iz trbu{ne aorte u eterskoj narkozi). Maseni udio Al u tkivu jetre odre|en je atomskom 
apsorpcijskom spektrometrijom. Histolo{ka analiza svjetlosnom mikroskopijom obavljena je nakon bojenja 
tkiva hematoksilinom i eozinom te histokemijski aurin trikarboksilnom kiselinom (aluminonom). Maseni 
udio aluminija u jetri izlo`enih {takorica bio je vi{i (37,12 µg g-1) nego u kontrolnoj skupini (0,71 µg g-1). U 
izlo`enih {takorica na|ene su kristaloidne inkluzije Al u kapsularnoj i supkapsularnoj zoni jetre i u portalnim 
prostorima. Osnovna struktura jetre je ostala o~uvana. U 16 od 20 izlo`enih i u 8 od 20 kontrolnih {takorica 
opa`ena je proliferacija ̀ u~nih kanali}a. Samo u tri izlo`ene {takorice na|ena je mikrovezikularna steatoza u 
jetrenom tkivu. Peritoneum i fibrozna (Glissonova) ovojnica jetre pokazivali su izrazitu infiltraciju makrofazima 
sli~nu “reakciji oko stranog tijela” s mjestimi~nim gigantskim stanicama u kojima su se nalazile kristaloidne 
inkluzije Al. Iako je infiltracija makrofaga obrambena reakcija kojom je najve}i broj ~estica Al zadr`an na 
mjestu ubrizgavanja, ~ini se da je dio tih ~estica prodro u tkivo jetre i izazvao toksi~ne reakcije u obliku 
proliferacije `u~nih kanali}a i mikrovaskularne steatoze.
KLJU^NE RIJE^I: aluminij, hepatotoksi~nost, kristaloidne inkluzije aluminija, laboratorijske {takorice, 
proliferacija `u~nih kanali}a
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